Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>
<p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2180/12/113 |
id |
doaj-5e24cc41a973428da10d8588874944d9 |
---|---|
record_format |
Article |
spelling |
doaj-5e24cc41a973428da10d8588874944d92020-11-25T01:33:48ZengBMCBMC Microbiology1471-21802012-06-0112111310.1186/1471-2180-12-113Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it>Filipiak WojciechSponring AndreasBaur MariaFilipiak AnnaAger ClemensWiesenhofer HelmutNagl MarkusTroppmair JakobAmann Anton<p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to develop a non-invasive method for the early detection of bacterial infection in ventilated patients, preferably allowing the identification of the specific pathogens. The present work is an attempt to identify pathogen-derived volatile biomarkers in breath that can be used for early and non- invasive diagnosis of ventilator associated pneumonia (VAP). For this purpose, <it>in vitro</it> experiments with bacteria most frequently found in VAP patients, i.e. <it>Staphylococcus aureus</it> and <it>Pseudomonas aeruginosa</it>, were performed to investigate the release or consumption of volatile organic compounds (VOCs).</p> <p>Results</p> <p>Headspace samples were collected and preconcentrated on multibed sorption tubes at different time points and subsequently analyzed with gas chromatography mass spectrometry (GC-MS). As many as 32 and 37 volatile metabolites were released by <it>S. aureus</it> and <it>P. aeruginosa</it>, respectively. Distinct differences in the bacteria-specific VOC profiles were found, especially with regard to aldehydes (e.g. acetaldehyde, 3-methylbutanal), which were taken up only by <it>P. aeruginosa</it> but released by <it>S. aureus</it>. Differences in concentration profiles were also found for acids (e.g. isovaleric acid), ketones (e.g. acetoin, 2-nonanone), hydrocarbons (e.g. 2-butene, 1,10-undecadiene), alcohols (e.g. 2-methyl-1-propanol, 2-butanol), esters (e.g. ethyl formate, methyl 2-methylbutyrate), volatile sulfur compounds (VSCs, e.g. dimethylsulfide) and volatile nitrogen compounds (VNCs, e.g. 3-methylpyrrole).</p> <p>Importantly, a significant VOC release was found already 1.5 hours after culture start, corresponding to cell numbers of ~8*10<sup>6</sup> [CFUs/ml].</p> <p>Conclusions</p> <p>The results obtained provide strong evidence that the detection and perhaps even identification of bacteria could be achieved by determination of characteristic volatile metabolites, supporting the clinical use of breath-gas analysis as non-invasive method for early detection of bacterial lung infections.</p> http://www.biomedcentral.com/1471-2180/12/113Volatile organic compounds (VOCs)Gas chromatography mass spectrometry (GCMS)Breath analysis<it>In vitro</it> headspace samplingAdsorptive enrichmentMultibed sorption tubesVolatile metabolites<it>Staphylococcus aureus</it><it>Pseudomonas aeruginosa</it> |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Filipiak Wojciech Sponring Andreas Baur Maria Filipiak Anna Ager Clemens Wiesenhofer Helmut Nagl Markus Troppmair Jakob Amann Anton |
spellingShingle |
Filipiak Wojciech Sponring Andreas Baur Maria Filipiak Anna Ager Clemens Wiesenhofer Helmut Nagl Markus Troppmair Jakob Amann Anton Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> BMC Microbiology Volatile organic compounds (VOCs) Gas chromatography mass spectrometry (GCMS) Breath analysis <it>In vitro</it> headspace sampling Adsorptive enrichment Multibed sorption tubes Volatile metabolites <it>Staphylococcus aureus</it> <it>Pseudomonas aeruginosa</it> |
author_facet |
Filipiak Wojciech Sponring Andreas Baur Maria Filipiak Anna Ager Clemens Wiesenhofer Helmut Nagl Markus Troppmair Jakob Amann Anton |
author_sort |
Filipiak Wojciech |
title |
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
title_short |
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
title_full |
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
title_fullStr |
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
title_full_unstemmed |
Molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
title_sort |
molecular analysis of volatile metabolites released specifically by <it>staphylococcus aureus</it> and <it>pseudomonas aeruginosa</it> |
publisher |
BMC |
series |
BMC Microbiology |
issn |
1471-2180 |
publishDate |
2012-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>The routinely used microbiological diagnosis of ventilator associated pneumonia (VAP) is time consuming and often requires invasive methods for collection of human specimens (e.g. bronchoscopy). Therefore, it is of utmost interest to develop a non-invasive method for the early detection of bacterial infection in ventilated patients, preferably allowing the identification of the specific pathogens. The present work is an attempt to identify pathogen-derived volatile biomarkers in breath that can be used for early and non- invasive diagnosis of ventilator associated pneumonia (VAP). For this purpose, <it>in vitro</it> experiments with bacteria most frequently found in VAP patients, i.e. <it>Staphylococcus aureus</it> and <it>Pseudomonas aeruginosa</it>, were performed to investigate the release or consumption of volatile organic compounds (VOCs).</p> <p>Results</p> <p>Headspace samples were collected and preconcentrated on multibed sorption tubes at different time points and subsequently analyzed with gas chromatography mass spectrometry (GC-MS). As many as 32 and 37 volatile metabolites were released by <it>S. aureus</it> and <it>P. aeruginosa</it>, respectively. Distinct differences in the bacteria-specific VOC profiles were found, especially with regard to aldehydes (e.g. acetaldehyde, 3-methylbutanal), which were taken up only by <it>P. aeruginosa</it> but released by <it>S. aureus</it>. Differences in concentration profiles were also found for acids (e.g. isovaleric acid), ketones (e.g. acetoin, 2-nonanone), hydrocarbons (e.g. 2-butene, 1,10-undecadiene), alcohols (e.g. 2-methyl-1-propanol, 2-butanol), esters (e.g. ethyl formate, methyl 2-methylbutyrate), volatile sulfur compounds (VSCs, e.g. dimethylsulfide) and volatile nitrogen compounds (VNCs, e.g. 3-methylpyrrole).</p> <p>Importantly, a significant VOC release was found already 1.5 hours after culture start, corresponding to cell numbers of ~8*10<sup>6</sup> [CFUs/ml].</p> <p>Conclusions</p> <p>The results obtained provide strong evidence that the detection and perhaps even identification of bacteria could be achieved by determination of characteristic volatile metabolites, supporting the clinical use of breath-gas analysis as non-invasive method for early detection of bacterial lung infections.</p> |
topic |
Volatile organic compounds (VOCs) Gas chromatography mass spectrometry (GCMS) Breath analysis <it>In vitro</it> headspace sampling Adsorptive enrichment Multibed sorption tubes Volatile metabolites <it>Staphylococcus aureus</it> <it>Pseudomonas aeruginosa</it> |
url |
http://www.biomedcentral.com/1471-2180/12/113 |
work_keys_str_mv |
AT filipiakwojciech molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT sponringandreas molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT baurmaria molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT filipiakanna molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT agerclemens molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT wiesenhoferhelmut molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT naglmarkus molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT troppmairjakob molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait AT amannanton molecularanalysisofvolatilemetabolitesreleasedspecificallybyitstaphylococcusaureusitanditpseudomonasaeruginosait |
_version_ |
1725075723923750912 |